<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01100788</url>
  </required_header>
  <id_info>
    <org_study_id>0806M37444</org_study_id>
    <nct_id>NCT01100788</nct_id>
  </id_info>
  <brief_title>Satiety Response of Short Chain Fructooligosaccharide</brief_title>
  <official_title>Satiety Response of Short Chain Fructooligosaccharide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Populations that report high fiber consumption demonstrate lower rates of obesity. Enhanced
      satiety may play a key role in this relationship. The colonic fermentation of fibers is
      theorized to influence satiety and food intake. Short chain fructooligosaccharide (scFOS) are
      rapidly fermentable fibers that can easily be added to foods to impact these parameters.

      The objective of this study was to evaluate the satiety response of scFOS and its ability to
      decrease food intake.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intervention study with fiber added to beverages and acute effects on satiety measured.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satiety response using visual analogue scales</measure>
    <time_frame>0, 15, 30, 45, 60, 90, 120, 180, 240 minutes postprandially</time_frame>
    <description>Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ad libitum food intake</measure>
    <time_frame>240 minutes postprandially and over 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breath hydrogen response</measure>
    <time_frame>0, 240 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal tolerance using visual analogue scales (VAS)</measure>
    <time_frame>24 hours</time_frame>
    <description>Subjective ratings of bloating, stool consistency, and flatulence on VAS. A stool count was also recorded.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scFOS 5 g</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 g scFOS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scFOS 8 g</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 g scFOS</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Short chain fructo-oligosaccharide (scFOS) 5 g</intervention_name>
    <description>Dietary Supplement: scFOS 5 g
Novel fiber administered in two 5 g doses--the first in a beverage and the second in a solid chew.</description>
    <arm_group_label>scFOS 5 g</arm_group_label>
    <other_name>fructo-oligosaccharide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Treatment without scFOS fiber</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Short chain fructooligosaccharide (scFOS) 8 g</intervention_name>
    <description>Novel fiber administered in two 8 g doses--the first in a beverage and the second in a solid chew.</description>
    <arm_group_label>scFOS 8 g</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women

          -  Age 18-64 years

          -  Non-smoking

          -  Not taking medication

          -  Non-dieting (weight stable in prior 3 months)

          -  BMI 18-27

          -  English literacy

        Exclusion Criteria:

          -  Do not regularly consume breakfast

          -  Food allergies to ingredients found in study products

          -  BMI &lt;18 or &gt;27

          -  Diagnosed cardiovascular, renal, or hepatic disease diabetes mellitus

          -  Cancer in previous 5 years (except basal cell carcinoma of the skin)

          -  Any gastrointestinal disease or condition

          -  Recent bacterial infection (&lt; 3 months)

          -  Recent or concurrent participation in an intervention research study

          -  History of drug or alcohol abuse in prior 6 months

          -  Use of lipid-lowering, anti-hypertensive, or anti-inflammatory steroid medication

          -  Eating disorder

          -  Vegetarians

          -  People who eat more than approximately 15 grams of fiber per day

          -  Women who are pregnant or lactating

          -  Women with irregular menstrual cycles
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanne Slavin</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2010</study_first_submitted>
  <study_first_submitted_qc>April 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2010</study_first_posted>
  <last_update_submitted>April 8, 2010</last_update_submitted>
  <last_update_submitted_qc>April 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Joanne Slavin</name_title>
    <organization>University of Minnesota</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

